Wilbert Jordan to Anti-HIV Agents
This is a "connection" page, showing publications Wilbert Jordan has written about Anti-HIV Agents.
Connection Strength
0.374
-
Jordan WC, Jefferson R, Yemofio F, Tolbert L, Conlon V, Carroll H, Green DC, Green A, Green R. Nevirapine plus efavirenz plus didanosine: a simple, safe, and effective once-daily regimen for patients with HIV infection. J Natl Med Assoc. 2003 Dec; 95(12):1152-7.
Score: 0.180
-
Beymer MR, Kofron RM, Tseng CH, Bolan RK, Flynn RP, Sayles JM, Perez MJ, Jordan WC, Landovitz RJ. Results from the post-exposure prophylaxis pilot program (P-QUAD) demonstration project in Los Angeles County. Int J STD AIDS. 2018 05; 29(6):557-562.
Score: 0.118
-
Campo RE, Narayanan S, Clay PG, Dehovitz J, Johnson D, Jordan W, Squires KE, Sajjan SG, Markson LE. Factors influencing the acceptance of changes in antiretroviral therapy among HIV-1-infected patients. AIDS Patient Care STDS. 2007 May; 21(5):329-38.
Score: 0.057
-
Wohl AR, Galvan FH, Myers HF, Garland W, George S, Witt M, Cadden J, Operskalski E, Jordan W, Carpio F, Lee ML. Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women? AIDS Behav. 2011 Aug; 15(6):1098-110.
Score: 0.019